SRI 31215 is a Matriptase/Hepsin/hepatocyte growth factor activator (HGFA) triplex inhibitor and mimics the activity of HAI-1/2 (endogenous inhibitors of HGF activation). SRI 31215 has potent inhibitory activity against matriptase, hepsin and HGFA with IC50 values of 0.69 µM, 0.65 µM and 0.30 µM, respectively. SRI 31215 can be used for the research of cancer[1].
Molecular Weight:
419.56
CAS Number:
[1832686-43-7]
Formula:
C25H33N5O
Target:
c-Met/HGFR
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted
